Left Atrial Thrombus in Atrial Fibrillation/Flutter Patients in Relation to Anticoagulation Strategy: LATTEE Registry.
Agnieszka Kapłon-CieślickaMonika GawalkoMonika BudnikBeata Uziębło-ŻyczkowskaPaweł KrzesińkiKatarzyna StarzykIwona Gorczyca-GłowackaLudmiła Daniłowicz-SzymanowiczDamian KaufmannMaciej WójcikRobert BłaszczykJarosław HiczkiewiczKatarzyna ŁojewskaKatarzyna Mizia-StecMaciej T WybraniecKatarzyna KosmalskaMarcin FijalkowskiAnna SzymańskaMirosław DłużniewskiMaciej HaberkaMichał KucioBłażej MichalskiKarolina KupczynskaAnna Tomaszuk-KazberukKatarzyna Wilk-ŚledziewskaRenata Wachnicka-TrutyMarek KozińskiPaweł BurchardtPiotr ScisłoRadoslaw PiatkowskiJanusz KochanowskiGrzegorz OpolskiMarcin GrabowskiPublished in: Journal of clinical medicine (2022)
The prevalence of LAT in AF is non-negligible even on chronic OAC. The risk of LAT seems higher on VKA compared to NOAC, and similar between different NOACs.
Keyphrases
- atrial fibrillation
- left atrial
- oral anticoagulants
- catheter ablation
- direct oral anticoagulants
- left atrial appendage
- end stage renal disease
- heart failure
- newly diagnosed
- ejection fraction
- percutaneous coronary intervention
- chronic kidney disease
- peritoneal dialysis
- left ventricular
- risk factors
- prognostic factors
- patient reported outcomes
- venous thromboembolism
- patient reported